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Although Bordetella pertussis has been observed to survive inside macrophages, its ability to resist or evade
degradation in phagolysosomes has not been defined. We here investigated the trafficking of B. pertussis upon
entry into human macrophages. During the first hours following phagocytosis, a high percentage of bacteria
were destroyed within acidic compartments positive for the lysosome-associated membrane proteins (LAMP).
However, roughly one-fourth of the bacteria taken up evade this initial killing event, remaining in nonacidic
compartments. Forty-eight hours after infection, the number of intracellular bacteria per cell increased,
suggesting that B. pertussis is capable of replicating in this type of compartment. Viable bacteria accumulated
within phagosomal compartments positive for the early endosomal marker Rab5 but not the late endosomal
marker LAMP. Moreover, B. pertussis-containing phagosomes acquired exogenously added transferrin, indi-
cating that intracellular bacteria have access to extracellular components and essential nutrients via the host
cell recycling pathway. Overall, these results suggest that B. pertussis survives and eventually replicates in
compartments with characteristics of early endosomes, potentially contributing to its extraordinary ability to
persist within hosts and populations.
Bordetella pertussis colonizes the human respiratory tract,
causing a disease known as whooping cough or pertussis, which
affects around 4 million people worldwide and causes more
than 300,000 deaths each year. Despite high vaccination rates,
whooping cough remains a serious threat to human health and
its incidence has been increasing in recent years in vaccinated
populations. Although some potential contributors to initial
colonization have been described, the mechanisms that allow
this pathogen to evade immune clearance and to cause the
extraordinarily prolonged disease known in China as Bai Ri Ke
(100-day cough) are not known.
B. pertussis expresses a number of potent virulence factors,
adhesins, and toxins (23) with known or predicted roles during
infection. Although B. pertussis is described as an extracellular
pathogen, several studies indicate that the immunomodulatory
properties of several of these virulence factors enable the bac-
terium to persist within epithelial cells and leukocytes (1, 3, 22,
24), leading to speculation that the infection might also com-
prise an intracellular stage. The dual extra- and intracellular
locations of B. pertussis are also consistent with the reported
need for both cellular and humoral immune responses for
bacterial elimination from the respiratory tract (12, 17, 33, 38).
It is presumed that macrophages play an important role in
the clearance of B. pertussis (21). However, in vitro studies
indicated that B. pertussis is capable of surviving intracellularly
in human macrophages for several days in the absence of
opsonins (11). Moreover, B. pertussis was found viable in alve-
olar macrophage cells of mice for more than 21 days after
infection (16). These observations have led to speculation that
alveolar macrophages might represent an intracellular niche
for B. pertussis (16, 41). The recovery of viable B. pertussis from
human hosts several weeks after infection (19, 30) and the
observation of B. pertussis within pulmonary alveolar macro-
phages of HIV-infected children (7) and in infants with con-
firmed B. pertussis pneumonia (28) provide support for this
theory.
Efforts to characterize the interaction between B. pertussis
and human macrophages have been mainly focused on B. per-
tussis adherence. Several B. pertussis virulence factors facilitate
interaction with phagocytes. B. pertussis fimbriae mediate the
binding to the very late antigen 5 receptor on monocytes and
macrophages, inducing the upregulation of complement recep-
tor 3 (CR3: CD11b/CD18) (14). CR3 expression is further
upregulated by pertussis toxin and filamentous hemagglutinin
(FHA) (18, 42). It has been demonstrated that CR3 serves as
a docking molecule for B. pertussis binding by FHA (18, 31),
which eventually leads to B. pertussis uptake in a nonbacteri-
cidal way (15). However, little is known about the fate of B.
pertussis inside macrophages. Recent studies by our group
showed that neutrophil uptake of B. pertussis in the absence of
specific antibodies leads to the failure of lysosomal maturation
and bacterial clearance (20). These observations are intriguing
evidence that B. pertussis has mechanisms that can allow for
evasion of phagolysosome biogenesis. However, short-lived
neutrophils are unlikely to provide a prolonged reservoir of
bacteria, and evasion of phagolysosome biogenesis in macro-
phages appears to be an important aspect of the persistence of
many other pathogens (9, 10, 29, 40).
The aim of this study was to determine the fate of B. pertussis
following phagocytosis by macrophages. Although many in-
gested bacteria were rapidly killed by macrophages, a signifi-
cant fraction of internalized B. pertussis was capable of evading
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phagosome-lysosome fusion, surviving for days and eventually
replicating in nonacidic compartments with characteristics of
early endosomes. These results reveal a pathway that may
contribute to both the extraordinarily long persistence of the
coughing illness caused by B. pertussis and its ability to persist
within largely immune populations.
MATERIALS AND METHODS
Bacterial strains and growth conditions. B. pertussis strain B213, a streptomy-
cin-resistant derivate of Tohama I, was transformed with plasmid pCW505 (43)
(kindly supplied by A. A. Weiss, Cincinnati, OH), which induces cytoplasmic
expression of green fluorescent protein (GFP) without affecting growth or anti-
gen expression (43). Bacteria were stored at 270°C and recovered by growth on
Bordet-Gengou (BG) agar plates supplemented with 15% defibrinated sheep
blood (bBGA) at 35°C for 3 days. Virulent bacteria were subsequently plated on
bBGA, cultured for 20 h at 35°C, and used in phagocytosis experiments.
Antibodies. The following antibodies were used: monoclonal antibody (MAb)
against human lysosome-associated membrane protein 1 (LAMP-1) (Pharmin-
gen, San Diego, CA), MAb against human Rab5 (Pharmingen, San Diego, CA).
CY3-conjugated goat F(ab)2 fragments of anti-rabbit immunoglobulin (Jackson
InmunoResearch, West Grove, PA), CY3-conjugated goat F(ab)2 fragments of
anti-mouse immunoglobulin (Molecular Probes, Eugene, OR). Immunoglobulin
G (IgG) fractions from pooled sera of pertussis patients with high anti-B. per-
tussis antibody titers, as measured by enzyme-linked immunosorbent assay (27),
were isolated as previously described (32). Polyclonal rabbit anti-B. pertussis
antiserum was obtained as described elsewhere (15).
Flow cytometry. Phycoerythrin (PE)-conjugated MAbs to CD14, to CD206,
and to CD11b; allophycocyanin-conjugated MAbs to CD11c; PE Cy5-conjugated
MAbs to CD1a; and the respective isotype controls were obtained from BD
Biosciences. GFP-expressing B. pertussis was used in experiments designed to
identify the phenotype of infected cells.
After staining, cells were washed and fixed in 1% paraformaldehyde before
analysis on a FACScalibur flow cytometer. Data were processed using the
CellQuest software (BD Biosciences). Histograms were draw from and mean
fluorescence intensity values were determined on the gated populations.
Macrophage isolation. Blood mononuclear cells from healthy volunteers were
isolated by Ficoll-Paque (GE Healthcare, Uppsala, Sweden) gradient centrifu-
gation as previously described (5). The mononuclear cell layer was washed and
suspended in Dulbecco’s modified Eagle medium (DMEM) containing 10%
inactivated autologous normal human serum (NS), added to six-well tissue cul-
ture plates (107 cells/well), and incubated for 2 h at 37°C in 5% CO2. Nonad-
herent cells were then removed by gentle washing (three times with DMEM–
10% NS), and adherent cells were cultured for an additional 6 days in DMEM
plus 10% NS prior to the addition of B. pertussis. Compared with recently
isolated monocytes (day 0), an increase in CD14, CD11c, CD11b, and CD206
was observed upon 6 days of differentiation, as expected for macrophage differ-
entiation. Forty-eight hours after B. pertussis infection, cells still exhibited mor-
phology typical of macrophages and a surface phenotype of CD141, CD1a2,
CD11b1, Cd11c1, and CD2061, as assessed by flow cytometry. It is noteworthy
that this was also the phenotype of the cells bearing B. pertussis growth, as
confirmed by gating on B. pertussis-positive cells and collecting 10,000 gated
events from the sample.
Macrophage infection assays. GFP-expressing B. pertussis was suspended in
DMEM plus 0.2% bovine serum albumin (BSA; Sigma), and the cells were
infected at a multiplicity of infection (MOI) of either 20 or 50 bacteria per cell.
Bacterial inocula were quantified by plating appropriate dilutions on bBGA. To
facilitate bacterial interaction with macrophages, plates were centrifuged for 5
min at 640 3 g. After 20 min of incubation at 37°C with 5% CO2, nonadherent
bacteria were removed by three washing steps. Unless indicated otherwise, 100
mg/ml polymyxin B sulfate (Sigma) was added for 1 h to kill extracellular bacteria
(6). Thereafter, the antibiotic concentration was decreased to 5 mg/ml. At ap-
propriate times of incubation (2, 24, and 48 h after infection), monolayers were
washed and B. pertussis intracellular survival was determined as follows. Infected
monolayers were scraped, and the number of viable eukaryotic cells was deter-
mined by Trypan blue dye exclusion. Next, macrophages were lysed with 0.1%
saponin in sterile water and serial dilutions of lysates were rapidly plated onto
bBGA plates to enumerate CFU.
Control experiments to assess the efficacy of antibiotic bactericidal activity
were performed in parallel. Briefly, samples of 5 3 108 bacteria were incubated
with antibiotics for 1 h at 37°C and plated on BG agar. This resulted in a 99.999%
decrease in CFU. Additionally, the number of CFU in cell culture supernatants
was examined. No viable bacteria were detected at any time postinfection.
In selected experiments, GFP-expressing B. pertussis was opsonized with hu-
man IgG (200 mg/ml) for 30 min at 37°C prior to incubation with macrophages
at an MOI of 20.
Quantification of phagocytosis. Opsonized or nonopsonized GFP-expressing
B. pertussis was suspended in DMEM plus 0.2% BSA. Macrophages were in-
fected at an MOI of 20 bacteria per cell as described before. After 20 min of
incubation at 37°C with 5% CO2, nonadherent bacteria were removed by three
washing steps prior to fixation with paraformaldehyde. The number of adherent
and phagocytosed bacteria per cell was estimated by fluorescence microscopy.
For this purpose, surface-bound bacteria were detected by incubation with rabbit
anti-B. pertussis IgG (30 min at 4°C), followed by incubation with CY3-conju-
gated goat F(ab)2 fragments of anti-rabbit immunoglobulin for another 30 min at
4°C. In experiments performed with opsonized bacteria, the remaining cell sur-
face-bound bacteria were detected by incubation (30 min at 4°C) with CY3-
conjugated goat F(ab)2 of anti-human IgG. To avoid eventual cytophilic binding
of antibodies to FcgR, all incubations were done in the presence of 25% heat-
inactivated human serum. After washing, samples were analyzed by fluorescence
microscopy using a DMLB microscope coupled to a DC100 camera (Leica
Microscopy Systems Ltd., Heerbrugg, Switzerland). The numbers of extracellular
(red and green) and intracellular (green) bacteria were evaluated by examination
of at least 100 macrophages. All experiments were carried out at least three times
in triplicate.
Confocal microscopy analysis. Colocalization studies were performed as de-
scribed before (32), with minor modifications. Briefly, macrophages incubated
with GFP-expressing bacteria at 37°C for 20 min were washed to remove non-
attached bacteria and further incubated either with 200 nM Lysotracker DND-99
(Molecular Probes) (5 min at 37°C), followed by fixation with paraformaldehyde,
or with 100 mg/ml polymyxin B (1 h at 37°C) for colocalization studies at later
time points. At 2, 24, and 48 h postinfection, macrophage samples were incu-
bated with or without Lysotracker stain prior to fixation with paraformaldehyde.
Those samples that were not incubated with Lysotracker stain were washed twice
with phosphate-buffered saline (PBS) and incubated for 10 min at room tem-
perature with PBS containing 50 mM NH4Cl. After two washing steps, cells were
incubated for 30 min with PBS containing 0.1% saponin (Sigma) and 0.5% BSA.
Next, cells were incubated for 1 h at 4°C with either mouse anti-human LAMP-1
monoclonal antibodies or mouse anti-human Rab5 antibodies in the presence of
0.1% saponin and 0.5% BSA. After three washing steps, macrophages were
incubated with the CY3-conjugated F(ab)2 fragment of goat anti-mouse for 30
min. To avoid cytophilic binding of antibodies to FcgR, all incubations were done
in the presence of 25% heat-inactivated human serum. Additionally, isotype
controls were run in parallel.
Microscopic analyses were performed using a confocal laser scanning micro-
scope (FV300; Olympus, Tokyo, Japan). The percentage of phagosomes con-
taining bacteria that colocalized with a given marker was calculated by analyzing
at least 50 phagosomes per donor.
Transferrin uptake. Transferrin uptake by macrophages was assayed as de-
scribed before (39), with minor modifications. Briefly, infected macrophages
were depleted of transferrin by incubation in DMEM containing 1% BSA for 1 h
at 37°C and further incubated for 10 min at 4°C with 10 mg/ml Alexa transferrin-
594 (Molecular Probes) in an excess of BSA (1%) to saturate nonspecific endo-
cytosis. Next, cells were incubated for 5 min at 37°C to allow internalization of
the ligand, washed with DMEM containing 1% BSA, and further incubated for
another 45 min at 37°C. Finally, the cells were fixed and microscopic analyses
were performed using a confocal laser scanning microscope (FV300; Olympus,
Tokyo, Japan). At least 50 bacteria per donor were analyzed for colocalization
with transferrin in each experiment.
Statistical analysis. Student’s t test (confidence level, 95%) or analysis of
variance (ANOVA) was used for statistical data evaluation. The significance of
the differences between the mean values of the data evaluated by ANOVA was
determined with the least significant difference test at a confidence level of 95%.
Results are shown as means and standard deviations (SD).
RESULTS
Time course of B. pertussis survival inside human macro-
phages. Previous studies have shown that in the absence of
opsonic antibodies, the uptake of B. pertussis by human neu-
trophils leads to the failure of cellular bactericidal activity (20).
However, neutrophils do not survive long enough to be an
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effective bacterial cellular reservoir. We therefore analyzed the
outcome of B. pertussis interaction with human macrophages, a
type of immune cell that lives longer in the body and is a
well-known cellular reservoir of several other bacterial patho-
gens.
We first examined the time course of the association be-
tween B. pertussis and human macrophages. To this end, mac-
rophages were incubated with bacteria for 20 min (MOI, 50),
extensively washed, and further incubated for 48 h. A consid-
erable increase in the bacterial loads of macrophages was ob-
served over time, as determined by confocal microscopy (Fig.
1). In control experiments with formalin-inactivated bacteria,
no increase in the number of intracellular bacteria was ob-
served under these experimental conditions (data not shown).
Interestingly, as time progressed, the number of intracellular
bacteria colocalizing with the acidotrophic dye Lysotracker
decreased significantly (Fig. 1). Although control experiments
showed that B. pertussis was unable to replicate in DMEM plus
NS (data not shown), this assay alone could not distinguish
bacterial division within macrophages from uptake of bacteria
still present in the surrounding of the cell despite the extensive
washing. We therefore examined the time course of intracel-
lular bacterial survival following a lower-MOI inoculation that
enabled the examination of phagosomes containing individual
bacteria. Synchronization of bacterial uptake was achieved by
low-speed centrifugation, followed by rapid warming to 37°C
for 20 min to allow phagocytosis to be completed. After exten-
sive washing, macrophages were incubated with polymyxin B to
kill the remaining extracellular bacteria, and the number of
remnant viable (intracellular) bacteria was determined at dif-
ferent times postinfection. The numbers of intracellular and
extracellular bacteria before antibiotic treatment were deter-
mined by double immunofluorescence staining. About 35% of
the macrophage-associated bacteria were found inside cells 20
min after inoculation (Fig. 2A). Figure 2B shows viable intra-
cellular bacteria as assessed by CFU counts after the killing of
extracellular bacteria. Relating these to the number of intra-
cellular bacteria, as assessed by double-staining microscopy
(Fig. 2A), demonstrated that 70% 6 15% of the ingested
bacteria were killed by the macrophages 2 h postinfection.
However, the surviving bacteria were able to replicate seven-
fold between 24 and 48 h postinfection (Fig. 2B). Importantly,
cells supporting bacterial growth 48 h after infection showed
macrophage characteristics, as assessed by flow cytometry
(data not shown).
Previous studies have shown that antibody opsonization of
B. pertussis significantly improves neutrophil uptake of B. per-
tussis and drastically changes the trafficking inside polymor-
phonuclear leukocytes (PMNs), leading to efficient bacterial
killing (32). A similar effect was observed in this study using
macrophages. Figure 2 shows that the presence of specific
antibodies enhanced macrophage bacterial uptake and intra-
cellular killing of B. pertussis at initial time points (around
94% 6 5% of the bacteria were killed). Importantly, no in-
crease in intracellular CFU was observed over the 48-h period,
suggesting that opsonization prevented the increase in the
number of viable intracellular bacteria.
Intracellular trafficking of B. pertussis. To better define the
time course of events involved in intracellular survival and
FIG. 1. Increase in the number of B. pertussis cells inside macro-
phages over time. GFP-expressing B. pertussis cells were incubated
with human macrophages (MOI, 50) for 20 min at 37°C. After being
washed, the macrophages were incubated for 2 h (panel a) or 48 h
(panel b) in DMEM–10% NS and further stained with the acidotropic
dye Lysotracker. Results representative of one out of three indepen-
dent experiments are shown.
FIG. 2. Phagocytosis and survival of B. pertussis in human macro-
phages. (A) GFP-expressing B. pertussis cells were incubated with
human macrophages (MOI, 20) for 20 min at 37°C. After being
washed, the cells were fixed and extracellular and intracellular bacteria
were quantified by double immunofluorescence staining. The data
represent the mean 6 SD of three independent experiments. The
number of intracellular IgG-opsonized B. pertussis bacteria was signif-
icantly different from the number of intracellular nonopsonized B.
pertussis bacteria (*, P , 0.05). (B) GFP-expressing B. pertussis was
incubated with human macrophages (MOI, 20) for 20 min at 37°C.
After three washing steps, the cells were incubated with polymyxin B to
kill extracellular bacteria and the number of CFU of B. pertussis per
cell was determined at different time points postinfection. The data
represent the mean 6 SD of three independent experiments. The
number of viable intracellular nonopsonized bacteria per cell at 48 h
postinfection was significantly different from the number of viable
intracellular bacteria per cell at both 2 and 24 h postinfection. (*, P ,
0.05).
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eventual replication of nonopsonized B. pertussis, we followed
the maturation of bacterium-containing phagosomes. We first
evaluated B. pertussis colocalization with the acidotropic dye
Lysotracker at different time points. We found 64% 6 6% of
the bacteria in Lysotracker-positive phagosomes as early as 20
min after infection. Two hours after infection, 80% 6 8% the
B. pertussis bacteria colocalized with acidic organelles, demon-
strating the fusion of bacterial phagosomes with lysosomes at
early stages of infection (Fig. 3). These results are consistent
with the drop in the number of viable intracellular bacteria
observed at these time points, suggesting that those bacteria
that were in Lysotracker-positive compartments at early times
postinfection were killed. However, at 48 h after infection,
coincident with the sevenfold increase in the number of live
bacteria inside the macrophages (Fig. 2), most of the B. per-
tussis-containing vacuoles were nonacidic, as attested by the
lack of accumulation of the acidotropic dye in 75% 6 6% of
the Bordetella-containing phagosomes (Fig. 3). The increase in
the number of intracellular bacteria per cell at 48 h postinfec-
tion suggests that some of the surviving bacteria at early time
points might have been able to replicate inside the macro-
phages in nonacidic compartments. To assess this possibility,
we monitored the overall levels of macrophage infection by
scoring the number of intracellular bacteria per macrophage
over time by fluorescence microscopy. One hundred macro-
phages were examined in each sample. The percentage of
macrophages loaded with a certain number of bacteria at each
time point was calculated from these data, and the results are
depicted in Fig. 4, which shows that at 2 h after infection, most
of the macrophages contained one to five bacteria. Twenty-two
hours later, an increase in the number of uninfected macro-
phages was observed, suggesting that some of the macrophages
cleared the bacteria upon infection. However, after 48 h, the
percentage of macrophages containing more than 10 bacteria
significantly increased whereas the percentage of macrophages
with one to five bacteria decreased. Together, these results
support the hypothesis that although many bacteria were effi-
ciently killed by macrophages, a number of the internalized
bacteria were able to avoid lysosome fusion and replicate in
nonacidic compartments.
We then investigated the characteristics of the B. pertussis-
containing compartments over time. As shown in Fig. 5, B.
pertussis-containing phagosomes were mainly positive for the
late endosomal/lysosomal marker LAMP-1 at 2 h postinfec-
tion, which is in line with the percentage of acidic phagosomes
found at this time point (Fig. 3). Forty-eight hours postinfec-
tion, the percentage of LAMP-positive B. pertussis phagosomes
FIG. 3. Time course of B. pertussis colocalization with the acidotropic dye Lysotracker. GFP-expressing B. pertussis bacteria were incubated with
human macrophages (MOI, 20) for 20 min at 37°C. After being washed, B. pertussis-infected macrophages were incubated with Lysotracker (20
min postinfection) or treated with polymyxin B before Lysotracker staining at 2 or 48 h after infection. The bars indicate percentages of
Lysotracker-positive phagosomes. The data represent the mean 6 SD of three independent experiments. Confocal microscopy images represen-
tative of one out of three independent experiments are shown.
FIG. 4. Quantification of bacterial loads in macrophages over time.
Macrophages incubated with GFP-expressing bacteria at 37°C for 20
min were washed and further incubated with polymyxin B to kill the
extracellular bacteria. At 2, 24, or 48 h after infection, cells were fixed
and the number of bacteria per macrophage (b/c) was analyzed by
fluorescence microscopy. The number of intracellular bacteria was
determined by analyzing 100 macrophages in each sample. The data
represent the mean 6 SD of three independent experiments.
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decreased to 13% 6 5%, suggesting that those bacteria that
successfully evaded lysosomal fusion eventually replicated in
compartments lacking lysosomal or late endosomal character-
istics. Accordingly, further characterization of these bacteri-
um-containing compartments demonstrated that they were
mainly positive for Rab5 (Fig. 5), an early endosomal marker.
B. pertussis access to exogenous material in macrophages.
Since B. pertussis was found located in early endosomal com-
partments, we next evaluated whether it has access to nutrients
via the recycling pathway. At 2 or 48 h postinfection, macro-
phages were pulsed with Alexa transferrin-594 as previously
described (39) to assess the access of bacterial compartments
to extracellular material. As shown in Fig. 5, at 2 h postinfec-
tion, only 5% 6 1% of the B. pertussis-containing phagosomes
were positive for transferrin. However, after 48 h, the percent-
age of transferrin-positive phagosomes significantly increased,
suggesting that bacteria have access to nutrients via recycling
endosomes, as expected for early endosomes and replicative
compartments.
DISCUSSION
Many persistent pathogens have evolved strategies to disrupt
normal endosomal maturation and fusion with lysosomes. Al-
though B. pertussis has not been traditionally considered an
intracellular pathogen, a substantial mass of evidence from cell
culture studies argues that this microorganism can invade and
persist in many cell types in laboratory cell culture models.
Intracellular survival would provide this pathogen with a niche
in which it could persist. The present study shows that B.
pertussis can not only persists for days inside human macro-
phages but also increases in numbers in compartments with
early endosomal characteristics.
The ability of professional phagocytes to ingest and kill mi-
croorganisms is central to innate immunity and host defense.
Microbial pathogens that can survive phagocytosis by neutro-
phils and macrophages have evolved diverse mechanisms to
enhance their survival within eukaryotic host cells (26). Some
of them, such as Listeria, Shigella, and Rickettsia bacteria, es-
cape into the cytoplasm to avoid lysosomal digestion. Others,
like Coxiella burnetii, have adapted to survive within the harsh
environment of the lysosome. A greater number of intracellu-
lar bacteria inhabit vesicles that do not fuse with lysosomes.
Although several in vitro and in vivo studies suggest that B.
pertussis is capable of surviving within macrophages (11, 16,
34), the intracellular trafficking of these bacteria has not been
determined. CR3 is probably the main receptor involved in
nonopsonized B. pertussis binding to phagocytes (25, 31). Bind-
ing to CR3 may be advantageous for bacteria, since ligation of
this receptor does not activate professional phagocytes (2).
Accordingly, nonopsonized B. pertussis failed to trigger a PMN
oxidative burst (32), which is consistent with the reported fail-
ure of activation of NADPH oxidase by independent ligation
of CR3. Recent in vitro studies by our group further showed
that after neutrophil uptake, nonopsonized B. pertussis can
survive within subcellular structures that do not undergo lyso-
somal maturation (20). Neutrophils, however, are unlikely cells
for the establishment of an intracellular reservoir since they
are short-lived. Macrophages, which are longer-lived, are bet-
FIG. 5. Characterization of B. pertussis-containing phagosome. Macrophages incubated with GFP-expressing B. pertussis at 37°C for 20 min
were washed and further incubated with polymyxin B. At 2 or 48 h after infection, macrophages were analyzed by confocal microscopy for Alexa
transferrin-594 uptake or LAMP-1 and Rab5 staining. The bars indicate percentages of LAMP-, Rab5-, and transferrin-positive phagosomes. The
data represent the mean 6 SD of three independent experiments. Representative confocal microscopy images of the colocalization of B. pertussis
with LAMP, Rab5, or transferrin in macrophages at 48 h postinfection are shown.
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ter suited to provide an intracellular niche to extend infection,
thereby increasing the opportunity for spread to new hosts.
Here we investigated the binding, phagocytosis, and intracel-
lular fate of B. pertussis when it encounters human macro-
phages. Our results showed that soon after bacterial phagocy-
tosis by macrophages, a considerable number of phagosomes
containing B. pertussis fused with lysosomes, as indicated by
bacteria colocalizing with LAMP-1 and with the acidotropic
dye Lysotracker. However, a large minority of bacteria were
found colocalizing with early endosomal markers 2 h after
infection and appeared to persist for days thereafter. B. per-
tussis seems to be unable to survive in acidic and LAMP-
positive compartments, as suggested by the concomitant drop
in the number of CFU recovered at this time point. These
results are in agreement with previous reports indicating that
B. pertussis is unable to survive at low pH (35). However, our
results further suggest that those bacteria that escape this ini-
tial killing event are able to replicate in nonacidic compart-
ments within 48 h after infection. Confocal analysis indicated
that, at this time point, the percentage of Lysotracker-positive
phagosomes drastically decreased, suggesting that those bac-
teria that were Lysotracker positive at earlier times postinfec-
tion were killed and subsequently degraded. In clear contrast,
opsonization of B. pertussis with IgG antibodies not only en-
hanced macrophage uptake and intracellular killing of B. per-
tussis but also prevented bacterial replication inside the cell.
This is consistent with previous in vivo and in vitro studies
showing that FcgR-mediated uptake facilitates B. pertussis
clearance, in contrast to uptake via CR3 (15, 32).
The survival of B. pertussis within vacuoles that remain in-
tegral to the endosomal network carries the risk of continued
sampling of bacterium-derived peptides and their presentation
to T cells. However, B. pertussis seems to have evolved strate-
gies to compromise the activation of T cells by the induction of
immunosuppressive cytokines such as interleukin-10 and
downregulation of HLA-DR and costimulatory molecules in
human monocytes (36). Boldrick et al. have profiled gene ex-
pression in total peripheral blood mononuclear cells infected
with B. pertussis in vitro and have found downregulation of
genes that encode major histocompatibility complex class II
molecules, the antigen presentation cofactor HLA-DM, the
lysosomal protease cathepsin B, and the lysosomal thiol reduc-
tase IP-30 (4), all of which are involved in antigen processing
and presentation.
Bacterial survival in a particular niche requires the develop-
ment of an adaptive response generally mediated by the up-
and/or downregulation of those genes required for physiolog-
ical adaptation to the environmental conditions. Although
little is known about B. pertussis adaptation to the intracellular
environment, both the BvgAS system and the RisAS system
have been found to be involved in such a response (22, 37).
Although this study was not focused on the bacterial factors
involved in survival inside cells, the fact that replication ap-
pears to proceed only after 24 h postinfection (Fig. 2B) may
reflect a delay before adaptation to environmental conditions
encountered within the macrophage.
To our knowledge, this is the first report that provides evi-
dence of an increase in the number of viable intracellular B.
pertussis bacteria, suggesting bacterial replication inside human
macrophages. Friedman and colleagues (11) did not find in-
tracellular replication. However, several publications since
their work have shed light on potential confounding factors in
that work, including mononuclear cell treatment prior to in-
fection, extracellular bacterial killing by complement present
in human serum (13), and CFU counts from monolayers with-
out taking into account the number of viable macrophages at
different time points, among others. With the advantage of this
knowledge, our assay were designed to avoid those prior prob-
lems.
Confocal analysis revealed that B. pertussis can survive in
compartments that are positive for the early endosomal
marker Rab5. This small GTPase functions as a regulatory
factor in the early endocytic pathway (8). Rab5 retention on
bacterium-containing vacuoles might inhibit further matura-
tion of the phagosome, as indicated by the low level of colo-
calization with LAMP at this time point, limiting the degrada-
tive capabilities and enhancing the odds for bacterial survival.
Since the ability of bacterial pathogens to survive within a cell
depends not only on their ability to avoid degradation in lyso-
somes but also on their capacity to obtain nutrients, our finding
that B. pertussis phagosomes acquire exogenously added trans-
ferrin not only confirms our previous observation that B. per-
tussis retards the maturation of its phagosome but also indi-
cates that there is exchange of material with the recycling
compartment, eventually granting the bacteria access to essen-
tial nutrients.
Overall, these findings support the hypothesis that B. pertus-
sis can survive and grow within macrophages. This may provide
substantial advantages aside from a temporary reprieve from
immune effectors. If local proinflammatory signals are re-
quired for efficient recruitment/activation of phagocytes, then
an intracellular niche could allow the pathogen to survive until
local inflammation has been modulated by the many anti-
inflammatory mechanisms, allowing it to emerge into a more
permissive environment. Alternatively, macrophages could
transport bacteria to new sites to initiate new microcolonies.
The identification of mutants lacking the ability to survive
within macrophages is critical to determining the role of this
ability in B. pertussis infection and persistence.
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